Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Conditions: Paget's Disease of the Bone; HypocalcemiaIntervention: Drug: ZOL446Sponsors: Novartis; Novartis PharmaceuticalsCompleted - verified February 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2008 Category: Research Source Type: clinical trials
Impact on Reducing the Incidence of Low Serum Calcium by Providing Educational Materials on the Need to Take Daily Supplemental Calcium and Vitamin D to Patients With Paget's Disease Treated With Reclast®
Conditions: Paget's Disease of the Bone; HypocalcemiaInterventions: Drug: Reclast (ZOL446, zoledronic acid); Dietary Supplement: Calcium; Dietary Supplement: Vitamin DSponsors: Novartis; Novartis PharmaceuticalsCompleted - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2008 Category: Research Source Type: clinical trials